Company intelligence / Profile preview

Fredun Pharmaceuticals

Mumbai, Maharashtra, Indiafredonnj.gov ↗

Ownership: Private
Development stage: Other

Overview

Fredun Pharmaceuticals has a broad commercial portfolio with over 450 products registered in overseas markets across 23 therapeutic classes. The company reported strong financial growth in FY25 with a net profit of Rs 2080.76 lakh (~$2.08 million) and revenue growth of over 30%. Recent expansions include new veterinary and petcare product launches[1].

Therapeutic areas: Metabolic DisordersEndocrinologyRheumatologyGastroenterologyCardiovascularInfectious Diseases
Modalities: Small moleculeBiologicDiagnostic kit
Industry: Biotech

Beyond the preview

Go deeper on Fredun Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fredun Pharmaceuticals.

Explore the full profile